Invenshure
Overview
Invenshure is a venture studio and venture capital firm that founds, builds, and invests in companies, transforming institutional intellectual property into commercial enterprises. The firm specializes in high-growth sectors including biotech, genomics, healthcare IT, diagnostics, and cloud computing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HistoSonics | Apr 2019 | Series C | - |
| Sonex Health | Nov 2020 | Debt | - |
| MEKanistic Therapeutics | Jul 2022 | VC Round | Lead |
| Exosite | Feb 2012 | Series A | Co-investor |
| Flywheel | Jun 2023 | Series D | Co-investor |
For institutional investors. Book with your work email.
Key People
Danny Cunagin
Chief Executive Officer
Troy Kopischke
Co-CEO & Co-Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Invenshure based?
Invenshure is headquartered in Minneapolis, Minnesota, United States.
When was Invenshure founded?
Invenshure was founded in 2011.
How many portfolio companies does Invenshure have?
Invenshure has 7 portfolio companies in Caplight's dataset.
What are some companies in Invenshure's portfolio?
Portfolio companies visible on Caplight include HistoSonics, Sonex Health, MEKanistic Therapeutics, Exosite, Flywheel.
What was Invenshure's most recent investment shown here?
Invenshure's most recent investment in this portfolio sample was in Flywheel in 2023.
What sectors does Invenshure focus on?
Invenshure focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software.
What company stages does Invenshure focus on?
Invenshure typically invests at the Early stage.